Search Results 491-500 of 16027 for pharmacogenetics

1. ICD-11 World Health Organization.

2. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

   This is a prospective, multicenter, randomized, double-blinded, placebo-controlled Phase 3 study of a microbiota suspension of intestinal microbes. Patients who ...

3. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

4. Update on hereditary gastrointestinal cancers: Lynch syndrome and familial adenomatous polyposis syndromes - Mayo Clinic

   A primer on Lynch syndrome, familial adenomatous polyposis (FAP) and attenuated FAP provides clinicians with tools to understand the genetic bases of these ...

5. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

   The purpose of this study is to evaluate the safety, tolerability, and preliminary effectiveness of ZB131 in patients with solid tumors where prevalence of CSP ...

6. Pemigatinib (oral route) - Mayo Clinic

   Pemigatinib is also used to treat myeloid/lymphoid neoplasms (blood cancer) that has come back or did not respond to treatment in patients who have a certain ...

7. Oncology (Medical) - Clinical trials - Mayo Clinic

   The purpose of this study is to evaluate nab-paclitaxel as maintenance therapy after cisplatin-based chemotherapy and surgery in treating patients with ...

8. Pulmonary Medicine Clinical Trials - Medical Professionals

   To determine the incidence of subclinical electrographic seizures and electrographic status epilepticus in children admitted to the PICU for head trauma, ...

9. clinicaltrials gov.

10. Felbamate (oral route) - Mayo Clinic

    Felbamate is used alone or together with other medicines to control partial seizures (convulsions) in the treatment of epilepsy, after other therapies have ...